Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog
click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.

Alan Franciscus
Editor-in-Chief
HCV Advocate
HBV Advocate

Wednesday, February 29, 2012

Panel Explores Hepatitis B Protection Strategies for Providers


ATLANTA – A federal vaccine advisory panel is considering options for ensuring that health care personnel who were vaccinated against hepatitis B in the remote past are currently protected. 

Increasing proportions of health care personnel were vaccinated against hepatitis B in infancy, or as a catch-up during adolescence. An estimated 90%-95% of healthy adults aged 40 years and younger achieve a protective antibody titer (defined as anti–hepatitis B surface antigen concentrations of 10 mIU/mL or greater) after receiving the three-dose series (MMWR 2011;60[RR07]:1-45). 

No comments:

Post a Comment